2.7
Goiter
Goiter refers to an abnormal enlargement of the thyroid gland that may appear as a diffuse goiter (uniform enlargement) or nodular (single or multiple…
A goiter is an abnormal enlargement of the thyroid gland. It may appear as a diffuse, uniform swelling or as a nodular enlargement with one or more nodules.
Diffuse goiters often result from chronic stimulation of thyroid tissue, which may develop due to elevated TSH levels, immune-mediated activation, or iodine deficiency.
In hyperthyroid goiters, such as those seen in Graves’ disease, autoantibodies called thyroid-stimulating immunoglobulins bind to TSH receptors, triggering excess hormone production.
In hypothyroid goiters, chronic elevation of TSH may develop due to autoimmune destruction of the thyroid, as seen in Hashimoto’s thyroiditis, or certain medications such as lithium.
Genetic defects affecting thyroid hormone synthesis can also lead to congenital goiters.
Over prolonged periods of stimulation, diffuse goiters may gradually become nodular and may eventually develop autonomous hormone production, resulting in toxic multinodular goiter. As goiters enlarge, they may exert mass effect on adjacent structures, leading to difficulty breathing or trouble swallowing.
View the full transcript and gain access to JoVE Core videos
Q1: What causes diffuse goiter to develop?
Diffuse goiter results from prolonged thyroid stimulation, commonly due to elevated TSH levels, immune-mediated activation, or iodine deficiency. In hypothyroid conditions like Hashimoto's thyroiditis, chronic TSH elevation drives thyroid enlargement. Conversely, in hyperthyroid conditions such as Graves' disease, thyroid-stimulating immunoglobulins directly stimulate the gland, causing diffuse enlargement despite normal or low TSH levels.
Q2: How does iodine deficiency lead to goiter?
Iodine is essential for thyroid hormone synthesis. When daily intake falls below 100 micrograms, hormone production becomes impaired. The pituitary responds by increasing TSH secretion to compensate, stimulating thyroid tissue growth. Severe deficiency below 10 micrograms per day dramatically elevates TSH levels, causing significant thyroid hypertrophy and visible goiter enlargement.
Q3: What are goitrogens and how do they affect the thyroid?
Goitrogens are substances that interfere with thyroid hormone synthesis. Dietary sources include cabbage, cassava, and turnips, while environmental agents include perchlorate and thiocyanate. Medications such as lithium, propylthiouracil, and methimazole also act as goitrogens. Despite goitrogen exposure, individuals often remain euthyroid because compensatory TSH elevation maintains adequate hormone production.
Q4: How can diffuse goiter progress to toxic multinodular goiter?
Over prolonged stimulation, diffuse goiter may gradually become nodular as thyroid tissue develops heterogeneous growth patterns. Some nodules eventually acquire autonomous hormone production independent of TSH control. This progression, especially in older individuals and sometimes triggered by increased iodine intake, results in toxic multinodular goiter, where nodules produce excess thyroid hormones.
Q5: What compressive symptoms can large goiters cause?
As goiters enlarge, they exert mass effect on adjacent structures. Tracheal compression causes respiratory difficulty and breathing problems. Esophageal compression leads to dysphagia or trouble swallowing. Venous compression can cause facial flushing and neck vein distension. Pemberton's sign—facial flushing and venous engorgement upon arm elevation—indicates superior vena cava compression from a large goiter.
Q6: What is the difference between nontoxic and toxic goiter?
Nontoxic goiter involves thyroid enlargement with normal or low hormone levels, often resulting from iodine deficiency or goitrogen exposure. Toxic goiter produces excess thyroid hormones, as seen in Graves' disease or toxic multinodular goiter. Both types can appear diffuse or nodular, but functional classification depends on whether the enlarged gland produces abnormal hormone levels.
Q7: How do genetic defects contribute to congenital goiter?
Genetic defects affecting thyroid hormone synthesis enzymes can impair the production of thyroid hormones from birth. The fetal pituitary responds by elevating TSH levels to compensate for inadequate hormone production. This chronic fetal TSH stimulation drives thyroid tissue growth in utero, resulting in congenital goiter that is typically associated with hypothyroidism ii pathophysiology complications.